Discovery & Development

Lipoprotein-nanoplatelets leave researchers hungry to explore drug delivery potential

How do we move on from a sombre start to 2016?

Many drug candidates are as poorly soluble as “brick dust”, making oral delivery a significant challenge.

From Iceland’s volcanic springs to a lab in South Denmark; does the microbe Sulfolobus. islandicus hold the key to a drug’s safe transit through the gut?

Digesting regulatory guidance is not always easy, but understanding the main points – and then paying attention to the details – will improve your chances of success.

Can R&D organizations really afford to kill off analytical data that could be used for future decision-making?

Polymorphic conversions are an ongoing problem in the pharmaceutical industry.

In an industry as diverse as pharmaceuticals, there is much that different disciplines can learn from each another.

A newly approved oncolytic immunotherapy takes on cancer using a live modified herpes virus

Could an ionic liquid–drug system help solve drug insolubility?